via UC San Francisco
Synthetic Molecules that Adhere Cells Could Galvanize Regenerative Medicine
Researchers at UC San Francisco have engineered molecules that act like “cellular glue,” allowing them to direct in precise fashion how cells bond with each other. The discovery represents a major step toward building tissues and organs, a long-sought goal of regenerative medicine.
Adhesive molecules are found naturally throughout the body, holding its tens of trillions of cells together in highly organized patterns. They form structures, create neuronal circuits and guide immune cells to their targets. Adhesion also facilitates communication between cells to keep the body functioning as a self-regulating whole.
In a new study, published in the Dec. 12, 2022, issue of Nature, researchers engineered cells containing customized adhesion molecules that bound with specific partner cells in predictable ways to form complex multicellular ensembles.
“We were able to engineer cells in a manner that allows us to control which cells they interact with, and also to control the nature of that interaction,” said senior author Wendell Lim, PhD, the Byers Distinguished Professor of Cellular and Molecular Pharmacology and director of UCSF’s Cell Design Institute. “This opens the door to building novel structures like tissues and organs.”
Regenerating Connections Between Cells
Bodily tissues and organs begin to form in utero and continue developing through childhood. By adulthood, many of the molecular instructions that guide these generative processes have disappeared, and some tissues, like nerves, cannot heal from injury or disease.
Lim hopes to overcome this by engineering adult cells to make new connections. But doing this requires an ability to precisely engineer how cells interact with one another.
“The properties of a tissue, like your skin for example, are determined in large part by how the different cells are organized within it,” said Adam Stevens, PhD, the Hartz Fellow in the Cell Design Institute and the first author of the paper. “We’re devising ways to control this organization of cells, which is central to being able to synthesize tissues with the properties we want them to have.”
We’re devising ways to control this organization of cells, which is central to being able to synthesize tissues with the properties we want them to have.
Much of what makes a given tissue distinct is how tightly its cells are bonded together. In a solid organ, like a lung or a liver, many of the cells will be bonded quite tightly. But in the immune system, weaker bonds enable the cells to flow through blood vessels or crawl between the tightly bound cells of skin or organ tissues to reach a pathogen or a wound.
To direct that quality of cell bonding, researchers designed their adhesion molecules in two parts. One part of the molecule acts as a receptor on the outside of the cell and determines which other cells it will interact with. A second part, inside the cell, tunes the strength of the bond that forms. The two parts can be mixed and matched in a modular fashion, creating an array of customized cells that bond in different ways across the spectrum of cell types.
The Code Underlying Cellular Assembly
Stevens said these discoveries also have other applications. For example, researchers could design tissues to model disease states, to make it easier to study them in human tissue.
Cell adhesion was a key development in the evolution of animals and other multicellular organisms, and custom adhesion molecules may offer a deeper understanding of how the path from single to multicellular organisms began.
“It’s very exciting that we now understand much more about how evolution may have started building bodies,” he said. “Our work reveals a flexible molecular adhesion code that determines which cells will interact, and in what way. Now that we are starting to understand it, we can harness this code to direct how cells assemble into tissues and organs. These tools could be really transformative.”
Original Article: Cellular “Glue” to Regenerate Tissues, Heal Wounds, Regrow Nerves
More from: University of California San Francisco | University of California Berkeley
The Latest Updates from Bing News
Go deeper with Bing News on:
- iOS 16.4: How to Enable Voice Isolation for Cellular Phone Calls
In iOS 16.4, Apple has made its Voice Isolation feature available for use during cellular calls. Keep reading to learn what Voice Isolation does and how to enable it. In iOS 15, Apple added ...
- hot glue
Many hackers would argue that the third essential tool should be hot glue — it stops stuff from moving, but still allows you to move it later if you decide that’s better after all. It also ...
- Saving Your Vision From Super Glue In The Eyes
Super glue, or cyanoacrylate as it is formally known, is one heck of a useful adhesive. Developed in the 20th century as a result of a program to create plastic gun sights, it is loved for its ...
- GLUE Monte Rosa Therapeutics, Inc.
- U.S. Cellular Reviews
See reviews below to learn more or submit your own review. How do I know I can trust these reviews about U.S. Cellular? How do I know I can trust these reviews about U.S. Cellular? 4,212,829 ...
Go deeper with Bing News on:
- Germany Cell and Gene Therapy Market - Focused Insights 2023-2028: Sector to Reach $3.44 Billion by 2028 at a 40% CAGR
and cell/tissue-based products derived from patients' blood are also covered in the report. Tissue-engineered products and tissue grafts/scaffolds with synthetic mechanical structures are excluded ...
- Regeneron Jumps Into Cell Therapy via Alliance With Treg Startup Sonoma Bio
Regeneron is paying Sonoma Biotherapeutics $75 million to begin a partnership focused on developing cell therapies based on regulatory T cells, or Tregs. Each company brings technological capabilities ...
- Peninsula cell therapy company lands big deal with Regeneron
As Sonoma Biotechnologies Inc. moves closer to putting its own cell therapy into a clinical trial in something other than cancer, it has lined up a partnership with Regeneron Pharmaceuticals Inc. that ...
- Cancer cells with thicker glycocalyx barrier are better at evading immune cells
One of the ways that cancer cells hide from the body's immune system is by forming a thin surface barrier called the glycocalyx. In a new study, researchers examined the material properties of this ...
- Scientists discover how cancer cells evade immune system
Cancer cells are notoriously hard to tackle as they hide from the body’s immune system by forming a thin surface barrier called the glycocalyx. A new study targets this process.